Biogen Inc. (BIIB)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 195.15 |
| Open | 195.37 |
| Bid | 192.08 x 100 |
| Ask | 192.28 x 100 |
| Day's Range | 192.01 - 195.54 |
| 52 Week Range | 192.01 - 319.76 |
| Volume | |
| Avg. Volume | 1,185,706 |
| Market Cap | 27.933B |
| Beta (5Y Monthly) | -0.01 |
| PE Ratio (TTM) | 24.11 |
| EPS (TTM) | 7.97 |
| Earnings Date | Apr 24, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 300.70 |
ZacksBiogen Inc. (BIIB) Reports Next Week: Wall Street Expects Earnings Growth
Biogen (BIIB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GuruFocus.comBiogen Is Suffering From Doubts About the Future
A closer look at one of the leaders in the global multiple sclerosis therapeutics market
Investor's Business DailyIs Eli Lilly Stock A Buy Or A Sell After FDA Delays Its Alzheimer's Drug Decision?
The FDA will now hold an advisory committee meeting to discuss Eli Lilly's Alzheimer's drug, donanemab. Is Eli Lilly stock a buy or a sell?
© 2024 Yahoo. All rights reserved.